Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

J & W PHARMLAB, LLC.

UEI: SJ4JFWZCYAK7

J & W PHARMLAB, LLC. is a federal contractor, registered under UEI SJ4JFWZCYAK7. It has been awarded $243,536 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

SJ4JFWZCYAK7

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

J & W PHARMLAB, LLC. specializes in pharmaceutical preparation manufacturing, with technical expertise in the procurement and supply of specialized chemical compounds. Their capabilities include the provision of complex organic molecules, such as (2R,4R)-(2-methyl-piperidin-4-yl)-carbamic acid tert-...

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

2

All time

Active

0

Currently performing

Completed

2

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency

Department Of Health And Human Services (hhs)$243.5K100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$243.5K100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with J & W PHARMLAB, LLC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for J & W PHARMLAB, LLC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in J & W PHARMLAB, LLC.'s top NAICS codes and agencies

Sterile Surgical Lubricant SupplierThis subcontract involves the supply of sterile, bacteriostatic, latex-free, and water-soluble surgical lubricant for prime contractors supporting Department of Defense Medical Supply Chain projects. The supplier is responsible for manufacturing or sourcing the lubricant according to NSN 6505-01-626-5774, with a specific delivery requirement of three boxes containing 144 units of 2.7g foil packets each. Strict adherence to regulatory and quality standards is mandatory, including FDA regulations, MIL-STD-2073-1E packaging guidelines, and Medical Marking Standard No. 1. Additionally, the supplier must ensure rigorous temperature control between 20 and 25 degrees Celsius to maintain product integrity. The opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Gasket Manufacturing and SupplyThis subcontract involves the manufacture and supply of 228 specialized gaskets for prime contractors supporting DLA Distribution supply contracts. The deliverables must be produced according to NSN/FSC 014351113/5330 specifications and adhere to MIL-STD-129 and MIL-STD-2073-1E standards for packaging and marking. A critical restriction is placed on the production process, as additive manufacturing is prohibited unless explicit authorization is granted by the contracting officer and ESA. Managed by the Department of Defense under the DLA Weapons Support Land Supplier Opns Vehicle Spt, the contract falls under NAICS code 325412. Performance will take place in New Cumberland, Pennsylvania. The solicitation was posted on November 6, 2026, with a response deadline of November 16, 2026.

DLA WEAPONS SUPPORT LAND SUPPLIER OPNS VEHICLE SPT

POSTED

DEADLINE

Supply of Self-Locking Hexagonal Nuts (NSN 5310-00-994-1670)This subcontract involves the supply of 78 self-locking hexagonal nuts, identified by NSN 5310-00-994-1670, to support prime contractors for the DLA Weapons Support ASC Commodities Division. The materials must be delivered FOB Origin to the DLA Distribution DDSP New Cumberland Facility in Pennsylvania. All supplied items are required to comply with the Buy American Act. Strict adherence to military standards is mandatory for this contract, including packaging per MIL-STD-2073-1E and marking per MIL-STD-129. Quality assurance will be conducted using zero-based sampling in accordance with MIL-STD-1916 or ASQ H1331. The solicitation was posted on November 6, 2026, with a response deadline of November 13, 2026.

DLA WEAPONS SUPPORT ASC COMMODITIES DIVISION

POSTED

DEADLINE

Maropitant Citrate Tablet ManufacturerThis subcontract involves the manufacture of FDA-regulated Maropitant Citrate 160mg tablets for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the full production cycle, including the chemical synthesis of the active pharmaceutical ingredient, formulation, tablet compression, and primary packaging into blister packs of four tablets per perforated sheet. To ensure quality and regulatory compliance, the manufacturer must utilize pharmaceutical-grade tablet presses and operate within cGMP-compliant facilities. The final deliverable consists of four packages of tablets that adhere to all medical specifications and maintain a minimum shelf-life of 36 months. This project falls under NAICS code 325412 and is performed at an APO location. Interested parties should note the response deadline of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Varicella Virus Vaccine ManufacturerThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires a manufacturer to provide live, lyophilized Varicella Virus Vaccine and corresponding diluents. The manufacturer must possess the necessary lyophilization equipment and FDA approval to produce the vaccine, ensuring a total shelf life of 18 months. Each delivery unit consists of one package containing 10 vaccine vials and 10 diluent vials. All packaging and labeling must strictly adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1B. The place of performance for this contract is located in Niagara Falls, New York. Interested parties should note the response deadline of November 12, 2026, for this pharmaceutical supply requirement under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Sodium Chloride and Hypodermic Needle SupplierThis subcontract, managed by the Department of Defense Medical Supply Chain MD SURG FSF, involves the supply of pre-filled sterile saline and sterile hypodermic needles to prime contractors. The specific requirements include 3 ml of 0.9 percent sodium chloride and 18 GA x 1.50 inch hypodermic needles. All provided materials must be FDA approved medical grade and adhere to a strict, non-extendable shelf-life of 12 months. The contract is categorized under NAICS code 325412 and specifies Montevideo as the place of performance. Interested parties should note the posting date of November 6, 2026, with a response deadline set for November 12, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Magnesium Sulfate Oral GranulesThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture or sourcing of Magnesium Sulfate oral granules for prime contractors. The specific requirements call for 495MG/5GM oral granules packaged in 454GM bags, with delivery consisting of one case containing 12 bags. A critical quality standard is the requirement for a non-extendable shelf life of 36 months. Compliance is mandatory regarding the Buy American Act, DLA Packaging Requirements RP001, and Medical Marking Standard No. 1. The project is categorized under NAICS code 325412, with the place of performance located at JBPHH in zip code 96860. Interested parties must adhere to the response deadline of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Isopropyl Alcohol USP (99%)This subcontract involves the supply of 99% Isopropyl Alcohol for prime contractors working on Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required product must be OTC-grade, meet USP standards, and be provided in 16 oz containers. To ensure product integrity, the supplier must maintain storage temperatures between 20 and 25 degrees Celsius in accordance with USP controlled room temperature standards. The selected supplier is responsible for providing Material Safety Data Sheets and ensuring full USP compliance. Delivery of the bottled alcohol is required FOB Destination to the specified place of performance. This opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Isoniazid Tablets (USP 300 MG)This subcontract involves the supply of USP 300 MG Isoniazid Tablets to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must manufacture or wholesale tablets that adhere to USP standards, ensuring a non-extendable shelf life of 36 months. All production and storage must occur within FDA-regulated pharmaceutical facilities maintained at medical controlled room temperature, with deliveries consisting of two bottles of 100-count tablets. The opportunity is categorized under NAICS code 325412 and is associated with a place of performance in FPO 96678. Interested parties must adhere to the timeline established by the posting date of November 6, 2026, with a response deadline set for November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-27-T-1528

Solicitation SPE2DS-27-T-1528, issued by the Defense Logistics Agency, is for the procurement of DPD Total Chlorine Reagent under NSN 6550-01-460-7597. The requirement consists of powder pillows with a 10 ML sample size, issued in packages of 100 units each. The total quantity requested is 101 packages, with delivery required within 20 days. Delivery is FOB Destination, with shipments directed to the USS Santa Barbara LCS 32 and the USS Hopper DDG 70. The reagents must have a non-extendable shelf life of 60 months, and no more than 8 months may have elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and sealed to prevent damage, adhering to Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be labeled according to the Hazard Communication Standard and packaged per TQ requirement IP025. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. The contract incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ISOPROPYL ALCOHOL

Solicitation # SPE2DP-27-T-0256

Solicitation SPE2DP-27-T-0256, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Isopropyl Alcohol USP (rubbing alcohol). The required product must have a concentration of 99% Isopropanol and be issued in bottles containing 473 milliliters, 1 pint, or 16 ounces. The contract specifies a delivery period of 20 days after receipt of order, with the place of performance located in FPO, ZIP 96692, and terms set as FOB Destination. Inspection and acceptance will occur at the destination per FAR 52.246-2. Due to the highly flammable nature of the material, the contract mandates strict hazardous materials compliance. This includes providing a current Material Safety Data Sheet (MSDS) via the DLA electronic mailbox and accompanying every shipment. Packaging must adhere to TQ requirement IP025, MIL-STD-129, and DLAI 4145.3 for military aircraft shipments, while labeling must comply with 49 CFR, 29 CFR, and Medical Marking Standard No. 1. The contractor must provide a signed certification of package configuration on the DD Form 250 and maintain packaging test reports for three years. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and adherence to the Buy American Act and NIST SP 800-171 cybersecurity standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RABIES VACCINE, VETERIN

Solicitation # SPE2DP-27-T-0253

Solicitation SPE2DP-27-T-0253, managed by the DLA Medical Supply Chain Pharm FSA, is for the procurement of one package of 50 units of IMRAB 3 veterinary rabies vaccine. The required product is a thimerosal-free, killed virus, 3-year vaccine (NSN 6509-01-526-5369) manufactured by Boehringer Ingelheim Animal Health USA. Due to the nature of the drug, it must be stored refrigerated between 2-8 degrees Celsius and must not be frozen. The item has a non-extendable shelf life of 24 months. Delivery is required within 84 days after order (ADO) with FOB Destination terms, with the inspection and acceptance points also set at the destination. The shipment is destined for the USA Med Mat Ctr EUR in Kaiserslautern, Germany. Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, and the contractor must provide a Safety Data Sheet prior to award. Administrative requirements include the use of the Wide Area Workflow (WAWF) system for invoicing and adherence to various FAR and DFARS clauses, including those regarding hazardous material identification, cybersecurity safeguarding, and the Buy American program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ISONIAZID TABLETS

Solicitation # SPE2DP-27-T-0255

This contract, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Isoniazid Tablets (NSN 6505-00-132-6904). The requirement is for two bottles of USP 300 MG tablets in quantities of 100 per bottle, which must be stored at medical controlled room temperature. The items have a non-extendable shelf life of 36 months and are regulated by the FDA. Delivery is specified as FOB Destination to the USS Stockdale DDG 106, with a required delivery timeframe of 20 days. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129 and Medical Marking Standard No. 1. Depending on the hazardous classification per FED-STD-313, packaging must follow either TQ requirement IP025 or ASTM D3951, with DLA Master List requirements taking precedence. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic material restrictions, and subcontracting for commercial products.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0248

This procurement is for the supply of Varicella Virus Vaccine, Live, Lyophilized, under solicitation SPE2DP-27-T-0248. The requirement is for one package consisting of 10 single dose vials of live vaccine and 10 vials of diluent, totaling 20 vials. The product must be drop shipped directly from the manufacturer and stored frozen between -50C and -15C. It must have a total shelf life of 18 months, with at least 15 months remaining upon delivery to the government. Delivery is required within 20 days, FOB Destination, to a facility in Niagara Falls, New York. The contract mandates strict adherence to MIL-STD-2073-1E and Medical Marking Standard No. 1B for packaging and labeling. Inspection and acceptance will occur at the destination per FAR 52.246-2. The solicitation incorporates various DFARS and FAR clauses, including requirements for safeguarding covered defense information, Buy American and Balance of Payments programs, and prohibitions on certain telecommunications equipment. All quotes must be submitted via the DLA Internet Bid Board System, and payment processing is handled through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

«Фармацевтична продукція» (Електроліти (Electrolytes))

Solicitation # UA-2026-11-06-013956-a

This solicitation, issued by the Military Medical Clinical Center of the Central Region for the Government of Ukraine, concerns the procurement of pharmaceutical electrolytes. The required product is an infusion solution packaged in 500 ml bottles, consisting of a specific combination of magnesium chloride hexahydrate, potassium chloride, calcium chloride dihydrate, sodium chloride, L-malic acid, and sodium acetate trihydrate. The supplier must ensure that the goods are delivered based on the customer's request and maintain at least 70% of their total manufacturer-defined shelf life upon delivery. Additionally, the contract strictly prohibits goods originating from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. The performance of the contract is located in the Vinnytsia region of Ukraine.

Військово-медичний клінічний центр Центрального регіону

POSTED

DEADLINE

Супозиторії ректальні в комбінації з екстрактом беладони 100 мг/20 мг/50 мг

Solicitation # UA-2026-11-06-012098-a

This solicitation, issued by the Health Care Center of the State Criminal Executive Service of Ukraine, seeks the procurement of rectal suppositories combined with belladonna extract in dosages of 100 mg, 20 mg, and 50 mg. The tender is managed by the Government of Ukraine with the primary point of contact being Irina Plakhotnik. The performance of the contract will take place in Kyiv, Ukraine. Interested participants must submit their responses by November 11, 2026. A critical requirement for submission is that the bidder must confirm that the proposed goods do not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Detailed information and submission portals are available through the Prozorro electronic system under solicitation number UA-2026-11-06-012098-a.

ДЕРЖАВНА УСТАНОВА "ЦЕНТР ОХОРОНИ ЗДОРОВ'Я ДЕРЖАВНОЇ КРИМІНАЛЬНО-ВИКОНАВЧОЇ СЛУЖБИ УКРАЇНИ"

POSTED

DEADLINE

Лікарські засоби різні: Електроліт, розчин (калію хлориду 5,0 мг, глюкози моногідрату 50,0 мг) 200 мл; Електроліти та комбінації розчин для інфузій по 500 мл (натрію хлориду : 0,526 г;натрію глюконату : 0,502 г; натрію ацетату тригідрату : 0,368 г; калію

Solicitation # UA-2026-11-06-010833-a

This solicitation, issued by the State Institution Eastern Territorial Medical Association of the Ministry of Internal Affairs of Ukraine, concerns the procurement of various medicinal electrolytes. The primary requirement is for an infusion solution packaged in 500 ml bottles, containing a specific composition of sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride, and magnesium chloride hexahydrate. Additionally, the contract covers electrolyte solutions containing potassium chloride and glucose monohydrate in 200 ml volumes. The procurement process is identified by solicitation number UA-2026-11-06-010833-a and was posted on November 6, 2026, with a response deadline set for November 11, 2026. The performance of the contract will take place within the Dnipropetrovsk region of Ukraine. Interested parties may coordinate with the primary point of contact, Oksana Kuksenko, regarding the submission of responses.

Державна установа «Східне територіальне медичне об’єднання Міністерства внутрішніх справ України»

POSTED

DEADLINE

Sirturo (Bedaquiline) tablets for the NIH (Notice of Intent to sole source)

Solicitation # NOI-27-000056

The National Institutes of Health Clinical Center intends to negotiate a sole source contract with Cardinal Health for the procurement of Sirturo (Bedaquiline) tablets. These medications, required for patient care in clinical research protocols, include 100 mg tablets in 188 count bottles and 20 mg tablets in 60 count bottles. The program anticipates an annual requirement of approximately 12 to 36 bottles of each dosage. Cardinal Health is identified as the sole source provider because the manufacturer, Janssen Therapeutics, has designated them as the exclusive distributor in the United States. This status was further confirmed through previous market research and a recent request for quotes that yielded no other respondents. Delivery is expected within 30 days of the award to the NIH Clinical Center in Bethesda, Maryland.

National Institutes Of Health - Cc

POSTED

DEADLINE